Pinnacle Wealth Planning Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $943K | Sell |
7,465
-101
| -1% | -$13.3K | 0.09% | 126 |
|
|
2026
Q1 | $1.05M | Sell |
7,566
-237
| -3% | -$33.2K | 0.11% | 106 |
|
|
2025
Q4 | $958K | Sell |
7,803
-157
| -2% | -$19.1K | 0.1% | 101 |
|
|
2025
Q3 | $884K | Buy |
7,960
+1,007
| +14% | +$114K | 0.1% | 114 |
|
|
2025
Q2 | $771K | Buy |
6,953
+1,302
| +23% | +$139K | 0.1% | 123 |
|
|
2025
Q1 | $633K | Buy |
5,651
+76
| +1% | +$7.84K | 0.1% | 131 |
|
|
2024
Q4 | $515K | Sell |
5,575
-2,128
| -28% | -$192K | 0.08% | 152 |
|
|
2024
Q3 | $646K | Sell |
7,703
-57
| -0.7% | -$4.35K | 0.09% | 149 |
|
|
2024
Q2 | $532K | Sell |
7,760
-126
| -2% | -$8.41K | 0.08% | 165 |
|
|
2024
Q1 | $578K | Sell |
7,886
-954
| -11% | -$73.4K | 0.08% | 159 |
|
|
2023
Q4 | $716K | Sell |
8,840
-146
| -2% | -$11.4K | 0.11% | 119 |
|
|
2023
Q3 | $673K | Sell |
8,986
-58
| -0.6% | -$4.46K | 0.11% | 119 |
|
|
2023
Q2 | $697K | Sell |
9,044
-176
| -2% | -$14K | 0.11% | 124 |
|
|
2023
Q1 | $765K | Sell |
9,220
-3
| -0% | -$248 | 0.13% | 118 |
|
|
2022
Q4 | $792K | Sell |
9,223
-238
| -3% | -$18.8K | 0.14% | 101 |
|
|
2022
Q3 | $583K | Buy |
9,461
+323
| +4% | +$20.4K | 0.11% | 124 |
|
|
2022
Q2 | $565K | Buy |
9,138
+2,667
| +41% | +$165K | 0.1% | 138 |
|
|
2022
Q1 | $385K | Sell |
6,471
-1,295
| -17% | -$82.8K | 0.07% | 217 |
|
|
2021
Q4 | $564K | Buy |
7,766
+302
| +4% | +$20.8K | 0.11% | 142 |
|
|
2021
Q3 | $521K | Buy |
7,464
+286
| +4% | +$20.1K | 0.12% | 131 |
|
|
2021
Q2 | $494K | Buy |
7,178
+389
| +6% | +$26K | 0.11% | 138 |
|
|
2021
Q1 | $438K | Buy |
6,789
+1,757
| +35% | +$113K | 0.11% | 145 |
|
|
2020
Q4 | $293K | Sell |
5,032
-531
| -10% | -$32K | 0.07% | 201 |
|
|
2020
Q3 | $352K | Sell |
5,563
-770
| -12% | -$53.4K | 0.12% | 136 |
|
|
2020
Q2 | $487K | Sell |
6,333
-176
| -3% | -$13.5K | 0.16% | 105 |
|
|
2020
Q1 | $485K | Buy |
6,509
+1,043
| +19% | +$72.1K | 0.23% | 88 |
|
|
2019
Q4 | $355K | Buy |
5,466
+929
| +20% | +$60.5K | 0.17% | 128 |
|
|
2019
Q3 | $287K | Buy |
4,537
+840
| +23% | +$54.9K | 0.16% | 127 |
|
|
2019
Q2 | $249K | Buy |
+3,697
| New | +$243K | 0.15% | 137 |
|
|
2018
Q4 | – | Sell |
-3,555
| Closed | -$274K | – | 164 |
|
|
2018
Q3 | $274K | Buy |
3,555
+105
| +3% | +$7.93K | 0.25% | 129 |
|
|
2018
Q2 | $244K | Sell |
3,450
-166
| -5% | -$11.7K | 0.24% | 139 |
|
|
2018
Q1 | $273K | Buy |
+3,616
| New | +$287K | 0.28% | 121 |
|
Other funds holding GILD
Pinnacle Wealth Planning Services's GILD Position: Q2 2026 in Review
Pinnacle Wealth Planning Services reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $13.3K and leaving 7,465 shares worth $943K. The position accounts for 0.09% of the portfolio, ranked #126.
Pinnacle Wealth Planning Services first reported a position in GILD in Q1 2018 and has held it in 32 quarters since. The position peaked at $1.05M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pinnacle Wealth Planning Services held 7,465 shares of Gilead Sciences worth $943K as of Q2 2026.
- Pinnacle Wealth Planning Services sold 101 Gilead Sciences shares in Q2 2026, an estimated $13.3K.
- Gilead Sciences made up 0.09% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #126 holding.
- Pinnacle Wealth Planning Services first reported a position in Gilead Sciences in Q1 2018 and has held it in 32 quarters since.
- Pinnacle Wealth Planning Services's Gilead Sciences position peaked at $1.05M in Q1 2026.
- 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.